2021 SIIA共识文件：睡眠障碍、高血压和心血管疾病的诊断和治疗方法

2021-02-25 High Blood Press Cardiovasc Prev . 2021 Feb 25.

2021年2月，意大利高血压学会(SIIA)发布了睡眠障碍、高血压和心血管疾病的诊断和治疗方法共识。高血压是致死性/非致死性心血管疾病的主要诱因，及时识别和适当管理影响高血压及其控制的因素是强制性公共

中文标题：

英文标题：

Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA)

发布机构：

发布日期：

2021-02-25

简要介绍：

2021年2月，意大利高血压学会(SIIA)发布了睡眠障碍、高血压和心血管疾病的诊断和治疗方法共识。高血压是致死性/非致死性心血管疾病的主要诱因，及时识别和适当管理影响高血压及其控制的因素是强制性公共卫生问题。本文主要总结了睡眠障碍与高血压和心血管疾病的最新证据，并针对其诊断和治疗提供共识指导。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=323c91c0020e2372, title=2021 SIIA共识文件：睡眠障碍、高血压和心血管疾病的诊断和治疗方法, enTitle=Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA), guiderFrom=High Blood Press Cardiovasc Prev . 2021 Feb 25., authorId=0, author=, summary=2021年2月，意大利高血压学会(SIIA)发布了睡眠障碍、高血压和心血管疾病的诊断和治疗方法共识。高血压是致死性/非致死性心血管疾病的主要诱因，及时识别和适当管理影响高血压及其控制的因素是强制性公共, cover=https://img.medsci.cn/2021324/1616578265724_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Feb 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年2月，意大利高血压学会(SIIA)发布了睡眠障碍、高血压和心血管疾病的诊断和治疗方法共识。高血压是致死性/非致死性心血管疾病的主要诱因，及时识别和适当管理影响高血压及其控制的因素是强制性公共卫生问题。本文主要总结了睡眠障碍与高血压和心血管疾病的最新证据，并针对其诊断和治疗提供共识指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=274, tagName=高血压)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=274, guiderKeyword=高血压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3314, appHits=317, showAppHits=0, pcHits=761, showPcHits=2997, likes=2, shares=15, comments=19, approvalStatus=1, publishedTime=Wed Mar 24 17:34:47 CST 2021, publishedTimeString=2021-02-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 24 17:31:15 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 12:06:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SIIA共识文件：睡眠障碍、高血压和心血管疾病的诊断和治疗方法.pdf)])

2021 SIIA共识文件：睡眠障碍、高血压和心血管疾病的诊断和治疗方法.pdf

下载请点击：

评论区 (12)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1076359, encodeId=5fc510e635963, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b05a5506635, createdName=Dr TL, createdTime=Thu Dec 02 22:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064418, encodeId=ece31064418e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fa75538820, createdName=ms2000000895204290, createdTime=Wed Oct 27 16:42:07 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999998, encodeId=8b699999989e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed2a5309565, createdName=14884544m19暂无昵称, createdTime=Fri Jul 16 12:03:03 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964608, encodeId=06cd9646087d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/c23834018c2b4a7aadd92aa67db56b99/4297da93ae384a7498c5f77b5d38dca8.jpg, createdBy=cb405428993, createdName=ms2000001721286033, createdTime=Tue May 11 15:26:08 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957128, encodeId=0b6195e12860, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:11 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
2021-12-02 Dr TL

学习了

52 0
[GetPortalCommentsPageByObjectIdResponse(id=1076359, encodeId=5fc510e635963, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b05a5506635, createdName=Dr TL, createdTime=Thu Dec 02 22:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064418, encodeId=ece31064418e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fa75538820, createdName=ms2000000895204290, createdTime=Wed Oct 27 16:42:07 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999998, encodeId=8b699999989e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed2a5309565, createdName=14884544m19暂无昵称, createdTime=Fri Jul 16 12:03:03 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964608, encodeId=06cd9646087d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/c23834018c2b4a7aadd92aa67db56b99/4297da93ae384a7498c5f77b5d38dca8.jpg, createdBy=cb405428993, createdName=ms2000001721286033, createdTime=Tue May 11 15:26:08 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957128, encodeId=0b6195e12860, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:11 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
2021-10-27 ms2000000895204290

学习

70 0
[GetPortalCommentsPageByObjectIdResponse(id=1076359, encodeId=5fc510e635963, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b05a5506635, createdName=Dr TL, createdTime=Thu Dec 02 22:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064418, encodeId=ece31064418e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fa75538820, createdName=ms2000000895204290, createdTime=Wed Oct 27 16:42:07 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999998, encodeId=8b699999989e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed2a5309565, createdName=14884544m19暂无昵称, createdTime=Fri Jul 16 12:03:03 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964608, encodeId=06cd9646087d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/c23834018c2b4a7aadd92aa67db56b99/4297da93ae384a7498c5f77b5d38dca8.jpg, createdBy=cb405428993, createdName=ms2000001721286033, createdTime=Tue May 11 15:26:08 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957128, encodeId=0b6195e12860, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:11 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
2021-07-16 14884544m19暂无昵称

学习

61 0
[GetPortalCommentsPageByObjectIdResponse(id=1076359, encodeId=5fc510e635963, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b05a5506635, createdName=Dr TL, createdTime=Thu Dec 02 22:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064418, encodeId=ece31064418e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fa75538820, createdName=ms2000000895204290, createdTime=Wed Oct 27 16:42:07 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999998, encodeId=8b699999989e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed2a5309565, createdName=14884544m19暂无昵称, createdTime=Fri Jul 16 12:03:03 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964608, encodeId=06cd9646087d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/c23834018c2b4a7aadd92aa67db56b99/4297da93ae384a7498c5f77b5d38dca8.jpg, createdBy=cb405428993, createdName=ms2000001721286033, createdTime=Tue May 11 15:26:08 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957128, encodeId=0b6195e12860, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:11 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
2021-05-11 ms2000001721286033

学习了

57 0
[GetPortalCommentsPageByObjectIdResponse(id=1076359, encodeId=5fc510e635963, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b05a5506635, createdName=Dr TL, createdTime=Thu Dec 02 22:29:20 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064418, encodeId=ece31064418e0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fa75538820, createdName=ms2000000895204290, createdTime=Wed Oct 27 16:42:07 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999998, encodeId=8b699999989e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed2a5309565, createdName=14884544m19暂无昵称, createdTime=Fri Jul 16 12:03:03 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964608, encodeId=06cd9646087d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/c23834018c2b4a7aadd92aa67db56b99/4297da93ae384a7498c5f77b5d38dca8.jpg, createdBy=cb405428993, createdName=ms2000001721286033, createdTime=Tue May 11 15:26:08 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957128, encodeId=0b6195e12860, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Thu Apr 15 00:01:11 CST 2021, time=2021-04-15, status=1, ipAttribution=)]
2021-04-15 梅干儿

三人行，必有我师。 #梅斯医学科研互助群# 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！

61 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021 SIIA共识文件：睡眠障碍、高血压和心血管疾病的诊断和治疗方法

相关指南

拓展阅读

科室

工具

服务